New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 30, 2014
13:15 EDTEXASExact Sciences could rise 50%, Barron's says
Exact Sciences shares could rise 50% fit the company's colon cancer test ramps up quickly, Barron's contends in a feature article. Short sellers are betting heavily against the company, the paper adds. Reference Link
News For EXAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
10:52 EDTEXASLeerink's life science tools analyst holds an analyst/industry conference call
Subscribe for More Information
08:05 EDTEXASExact Sciences says Tufts Health Plan to cover Cologuard
Subscribe for More Information
March 26, 2015
10:04 EDTEXASOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:23 EDTEXASOn The Fly: Pre-market Movers
Subscribe for More Information
06:07 EDTEXASExact Sciences downgraded to Neutral from Buy at Goldman
Goldman downgraded Exact Sciences to Neutral to reflect lower revenue estimates for Cologuard adoption. Price target lowered to $24 from $29.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use